On June 17, 2026, four insiders at Hemab Therapeutics Holdings, Inc. (COAG) executed significant share purchases, collectively acquiring approximately $6.15 million worth of stock. The transactions included purchases of 61,523 shares each by Capital Healthcare Fund Lp Ra, Capital Management, L.P. Ra, Peter Kolchinsky, and Rajeev M. Shah, all at a price of $24.98 per share.
These coordinated purchases by multiple insiders are often viewed as a strong bullish indicator by market observers. The individuals involved, including two 10% owners, have demonstrated a notable commitment to the company's stock through these transactions.
The cluster buying activity occurred amidst recent insider activity for Hemab Therapeutics, with RA Capital Healthcare Fund LP, RA Capital Management, L.P., Peter Kolchinsky, and Rajeev M. Shah all making various purchases in the days leading up to June 17th.